Author: Customer Service

Casino Group becomes PLESIO The Group is changing its name to PLESIO, adopting a new identity that underscores its positioning in convenience retail. This change applies to the Group. Its seven brands (Monoprix, Casino, Spar, Vival, Cdiscount, Franprix and Naturalia) will retain their names and identities. Since 2024, the Group has put convenience retail at the heart of its business and strategy. Its new identity reflects its ambition to build a retail business that brings people together and responds to the needs of each local community. This ambition is supported by the Group’s Renouveau 2030 strategic plan, which focuses on three key markets: daily food shopping, quick meal solutions and new everyday services. Philippe Palazzi, CEO of PLESIO said : «With our new identity, PLESIO, we are entering the next stage of the Group’s development,...

Disclosure of treasury shares transactions carried out from October 12 to October 16, 2026AttachmentBUREAU VERITAS – Reporting agrégé du 12 octobre au 16 octobre 2026 (vENG)

New Fire TV experience uses the familiar mechanics of streaming discovery to help people find their next night out Users can browse participating pubs and bars by “genre”, invite friends and receive a weekly credit for a Heineken or Heineken 0.0 The launch comes as over half of adults worldwide say they would go out more often if discovering where to go was as easy as discovering something to watchAMSTERDAM, Oct. 20, 2026 (GLOBE NEWSWIRE) — We’re all familiar with the new era of TV viewing: abundant choice, personalised recommendations and effortless discovery. Streaming has transformed how we discover entertainment, with something to watch just seconds away. Now, that same approach can help people discover where to go out, too. As much as people love the ease of streaming, they still crave time together IRL. The challenge is...

BEIJING, Oct. 20, 2026 (GLOBE NEWSWIRE) — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced that the ordinary resolution relating to the Company’s previously announced subscription, through a wholly owned subsidiary, for a limited partnership interest in Tianjin Lisi Xingshen Equity Investment Partnership (Limited Partnership), with a capital commitment of RMB1.5 billion, and the related transactions, as set forth in the notice of extraordinary general meeting dated September 24, 2026, has been duly passed at the extraordinary general meeting held in Beijing, China today. About Zhihu Inc. Zhihu Inc. (NYSE: ZH; HKEX: 2390) is a leading online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Since the initial...

Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech’s biosimilars portfolio REYKJAVIK, Iceland and LONDON, UK (October 20, 2026) – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announcedthat the U.S. Food and Drug Administration (FDA) has approved a new manufacturing process for SIMLANDI® (adalimumab-ryvk), Alvotech’s biosimilar to Humira® (adalimumab). The FDA approval allows Alvotech to introduce Process 2.0 for the manufacture of adalimumab drug substance in its DSM2 manufacturing suite in Reykjavik, Iceland. The new process more than doubles drug substance output per batch without changing the upstream manufacturing scale. The improvement was...

– Earnings Call Scheduled for 7:00 AM ET on November 10, 2026 – SHANGHAI, China, Oct. 20, 2026 (GLOBE NEWSWIRE) — Hesai Group (Nasdaq: HSAI; HKEX: 2525) (“Hesai” or the “Company”), a Physical AI infrastructure company, today announced that it will report its third quarter 2026 unaudited financial results on Tuesday, November 10, 2026, before the U.S. market opens. The Company’s management will host an earnings conference call at 7:00 AM U.S. Eastern Time on November 10, 2026 (8:00 PM Beijing/Hong Kong Time on November 10, 2026). For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes prior to the scheduled call start time. Upon registration, each participant will receive dial-in details to join the conference call.Event Title: Hesai...

Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech’s biosimilars portfolio REYKJAVIK, Iceland and LONDON, Oct. 20, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has approved a new manufacturing process for SIMLANDI® (adalimumab-ryvk), Alvotech’s biosimilar to Humira® (adalimumab). The FDA approval allows Alvotech to introduce Process 2.0 for the manufacture of adalimumab drug substance in its DSM2 manufacturing suite in Reykjavik, Iceland. The new process more than doubles drug substance output per batch without changing the upstream manufacturing scale. The improvement...

Water shortages will threaten growth within five years, say over half of European industrial leadersWater shortages will threaten growth within five years, say over half of European industrial leadersWater stress is already hitting operating costs, supply chains and infrastructure across European industry Water shortages now rank as high as cyber-attacks and supply chain disruption for industrial business continuity Nearly 60% of leaders admit to not installing the technology they know could cut water riskPARIS, Oct. 20, 2026 (GLOBE NEWSWIRE) — Schneider Electric, a global energy technology leader, today released The Water Crunch Report, new research revealing that water is now one of the biggest risks to industrial business continuity across the UK and Europe, ranking as highly as cyber-attacks and supply chain disruption....